IGF-1 (Biogen/Pharmacia & Upjohn)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIGF-1 (Biogen/Pharmacia & Upjohn)
Drug Alias NamerhIGF- IMecaserminSomatomedin 1Somatomedin CIgef
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsDwarfism
Global Approved IndicationsDwarfism
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date1994/01/01
Country/TerritorySweden
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiogen IncPharmacia & Upjohn
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDwarfism
Inactive IndicationsN/A

Other Information

ATC CodeH01AC03
Related LinksWikipediaDrugBank